“Our innovation aims to make blood draws fully autonomous, safer, faster, more accurate, less painful, and more accessible.” —Brian Joseph, co-founder, Vitestro CEO SUMMARY: Phlebotomy and collection of veinous blood is one important procedure in clinical laboratory testing that continues to be primarily a manual process. That is about to change. Netherlands-based Vitestro has obtained […]
Medical Robotics Developer Says It’s Time to Transform Phlebotomy
Newsmaker Interview
- By Robert Michel
- > From the Volume XXXII, No. 4 - March 10, 2025 Issue
- Tags: A.D.O.P.T., AI, Aletta, Aletta Autonomous Robotic Phlebotomy Device, american society of clinical pathology, Amsterdam University Medical Center, ARPD, artificial intelligence, autonomous blood draw, Autonomous Blood Drawing Optimization and Performance Trial, BMI, Bob Gerberich, body mass index, Brian Joseph, CE mark, difficult intravenous access, DIVA, doppler ultrasound, European Pivotal Trial, executive war college, FDA, Food and Drug Administration, IFCC WorldLab 2024, Medical robotics, near-infrared guided imaging, Netherlands Society for Clinical Chemistry and Laboratory Medicine, OLVG laboratory, patient-facing care, people, phlebotomy, Tracxn, U.S. Congress, veinous blood draw, Vitestro
